全部文献期刊会议图书|学者科研项目
中外文文献  中文文献  外文文献
作者:Dirk Rades , Daniel Seidl , Stefan Janssen ...
来源:[J].BMC Cancer(IF 3.333), 2016, Vol.16 (1)Springer
摘要:Abstract(#br) Background(#br)To compare definitive radiochemotherapy with weekly administration of 30–40 mg/m2 of cisplatin to 100 mg/m2 of cisplatin on days 1, 22 and 43 for outcomes and toxicity in patients with squamous cell carcinoma of the head-a...
作者:Lianhuang Li , Zhifen Chen , Xingfu Wang ...
来源:[J].BMC Cancer(IF 3.333), 2015, Vol.15 (1)Springer
摘要:Abstract(#br) Background(#br)Preoperative radiochemotherapy improves outcomes in patients with locally advanced rectal carcinoma, and has been used increasingly in patient management. However, there is a strong clinical need to assess tumor response to neoadjuvant treatment, and ...
作者:J. Gomez-Millan , B. Pajares , L. Perez-Villa ...
来源:[J].BMC Cancer(IF 3.333), 2016, Vol.16 (1)Springer
摘要:... To investigate the prognostic significance of pMEK expression in the nucleus and cytoplasm among patients with locally advanced head and neck cancer treated with concurrent radiochemotherapy.(#br) Methods(#br)Immunohistochemistry was performed on the retrieved archival tissue...
作者:Isolde Summerer , Julia Hess , Adriana Pitea ...
来源:[J].BMC Genomics(IF 4.397), 2015, Vol.16 (1)Springer
摘要:... In order to identify potential targets, we developed a HNSCC radiochemotherapy cell culture model of primary HNSCC cells derived from two different patients (HN1957 and HN2092) and applied an integrative microRNA (miRNA) and mRNA analysis in order to gain information on the b...
作者:Marion Rapp , Oliver M. Grauer , Marcel Kamp ...
来源:[J].Trials(IF 2.206), 2018, Vol.19 (1), pp.1-14DOAJ
摘要:Abstract Background Despite the combination of surgical resection, radio- and chemotherapy, median survival of glioblastoma multiforme (GBM) patients only slightly increased in the last years. Disease recurrence is definite with no effective therapy existing after tumor remo...
作者:Claudia Lill , Barbara Bachtiary , Edgar Selzer ...
来源:[J].Wiener klinische Wochenschrift(IF 0.813), 2017, Vol.129 (11-12), pp.398-403Springer
摘要:After publishing promising results for the treatment of patients with human papilloma virus (HPV) positive oropharyngeal cancer with radiochemotherapy regarding 2‑year survival, we present an update of the disease-specific and disease-free survival after 5 years.
作者:Tina Reis , Edwin Khazzaka , Grit Welzel ...
来源:[J].Radiation Oncology(IF 2.107), 2015, Vol.10 (1)Springer
摘要:Abstract(#br) Background(#br)Current therapeutic standard for locally advanced rectal cancer is the neoadjuvant radiochemotherapy with total mesorectal excision. Diarrhoea is the main acute side effect, induced by the dose to the small-bowel, frequently leading to a treatment mo...
作者:Cédric M. Panje , Laura Höng , Stefanie Hayoz ...
来源:[J].Radiation Oncology(IF 2.107), 2019, Vol.14 (1), pp.166Springer
摘要:... The aim of our study was therefore to determine the impact of sarcopenia on prospectively collected specific outcomes in a subgroup of patients treated within the phase III study SAKK 75/08 with trimodality therapy (induction chemotherapy, radiochemotherapy and surgery) for l...
作者:Marc D. Piroth , Norbert Galldiks , Michael Pinkawa ...
来源:[J].Radiation Oncology(IF 2.107), 2016, Vol.11 (1)Springer
摘要:...(#br) Methods(#br)A relapse pattern analysis was performed in 13 glioblastoma patients treated with radiochemotherapy within a prospective phase-II-study between 2008 and 2009. Radiotherapy was performed as an integrated-boost intensity-modulated radiotherapy (IB-IMRT). T...
作者:Susana Inogés , Sonia Tejada , Ascensión López-Díaz de Cerio ...
来源:[J].Journal of Translational Medicine(IF 3.459), 2017, Vol.15 (1)Springer
摘要:Prognosis of patients with glioblastoma multiforme (GBM) remains dismal, with median overall survival (OS) of about 15 months. It is therefore crucial to search alternative strategies that improve these results obtained with conventional treatments. In this context, immunoth...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×